ReviewCancer management and research2017

Rituximab in the treatment of follicular lymphoma: the future of biosimilars in the evolving therapeutic landscape.

Janakiraman Subramanian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.